What is the Next Generation Sequencing Market size in 2022?

The Next Generation Sequencing Market size is USD 7.6 billion for 2022.

What are the segments covered in the Next Generation Sequencing Market report?

Market.US has segmented the Global Next Generation Sequencing Market Value (US$ Mn) Analysis by Region, 2022 market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). Based on Technology Type, Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing. Based on Application,market is segmented into Oncology, Clinical Investigation, Reproductive Health, Metagenomics, Drug Discovery, Consumer Genomics. By Workflow, market is segmented into Pre-sequencing, Sequencing,NGS Data Analysis. Based on End-User, market is divided into Clinical Research, Hospitals and Clinics, Pharma and , Biotech Industries, Contract Research Organizations, Academic Research.

Who are the key players in the Next Generation Sequencing Market?

Illumina, Inc., Hoffman-La Roche, QIAGEN, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies, PierianDx Inc., Genomatix GmbH, DNASTAR, Inc., Perkin Elme Inc., Eurofins GATC Biotech GmbH, BGI, Precigen Inc., Macrogen Inc., Pillar Biosciences Inc., Agilent Technologies Inc., Other key players are the key vendors in the Next Generation Sequencing Market.

Which region is more attractive for vendors in the Next Generation Sequencing Market?

In 2022, North America was the major market player, accounting for the largest share of 43% of total revenues.

What is the CAGR for the Next Generation Sequencing Market?

The Next Generation Sequencing Market expected to grow at a CAGR of 14.6% during 2023-2032.

Global Next Generation Sequencing Market By Technology (Whole Genome Sequencing, Whole Exome Sequencing, and Others), By Application (Oncology, Clinical Investigation, and Others), By Workflow (Pre-sequencing, Sequencing, and NGS Data Analysis), By End-User (Clinical Research, Hospitals and Clinics, and Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Published date: Aug 2024
Report ID: 40038
Number of Pages: 206
Format:

- Illumina, Inc.
- Hoffman-La Roche
- QIAGEN NV Company Profile
- Thermo Fisher Scientific Company Profile
- Bio-Rad Laboratories, Inc. Company Profile
- Oxford Nanopore Technologies
- PierianDx Inc.
- Genomatix GmbH
- DNASTAR, Inc.
- Perkin Elme Inc.
- Eurofins GATC Biotech GmbH
- BGI
- Precigen Inc.
- Macrogen Inc.
- Pillar Biosciences Inc.
- Agilent Technologies Inc. Company Profile
- Other key players
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 40038
Published Date Aug 2024
Rating
- ★★★★★
  
  ★★★★★
- (43)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)